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INTRODUCTION 
 
Adult skeleton constantly undergoes bone remodeling to 
replace  old/damaged  bones  by  new  bones,  which  is 
required for the maintenance of bone shape and strength 
of adult skeleton. However, bone mass decreases and 
bone  fragility  increases  with  age  in  both  men  and 
women.  Although  an  increase  in  bone  resorption  rate 
associated with menopause is the primary cause of low 
bone mass in postmenopausal women, a decline in bone 
formation rate may also contribute to the loss of bone 
mass  in  both  postmenopausal  and  age-related 
osteoporosis. 
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In bone marrow, mesenchymal stem cell (bmMSC) is a 
small population of multipotent cells that are capable of 
self-renewal  proliferation  and  differentiating  into 
several  cell  lineages  such  as  osteoblast,  chondrocyte, 
and adipocyte [1]. Thus, bmMSC play a critical role in 
bone formation that occurs in the skeletal development 
and growth, in the maintenance of fully grown skeleton, 
and in fracture repair [2]. It is reasonable to assume that 
the osteogenic potential of bmMSC may decrease with 
age. Indeed, animal studies have shown that bmMSCs 
from aged rats are less responsive to growth factors than 
cells from adult rats, and that bmMSCs from old bone 
are  defective  in  bone  induction  potential  [3-6]. 
Gene expression profiling suggests a pathological role of human bone marrow-
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Abstract: Aging is associated with bone loss and degenerative joint diseases, in which the aging of bone marrow-derived 
mesenchymal stem cell (bmMSC)
1 may play an important role. In this study, we analyzed the gene expression profiles of 
bmMSC  from  14  donors  between  36  and  74  years  old,  and  obtained  age-associated  genes  (in  the  background  of 
osteoarthritis)  and  osteoarthritis-associated  genes  (in  the  background  of  old  age).  Pathway  analysis  of  these  genes 
suggests that alterations in glycobiology might play an important role in the aging of human bmMSC. On the other 
hand, antigen presentation and signaling of immune cells were the top pathways enriched by osteoarthritis-associated 
genes, suggesting that alteration in immunology of bmMSC might be involved in the pathogenesis of osteoarthritis. Most 
intriguingly, we found significant age-associated differential expression of HEXA, HEXB, CTSK, SULF1, ADAMTS5, 
SPP1, COL8A2, GPNMB, TNFAIP6, and RPL29; those genes have been implicated in the bone loss and the pathology of 
osteoporosis and osteoarthritis in aging. Collectively, our results suggest a pathological role of bmMSC in aging-related 
skeletal diseases, and suggest the possibility that alteration in the immunology of bmMSC might also play an important 
role in the etiology of adult-onset osteoarthritis. 
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1Abbreviations: bmMSC, bone marrow-derived mesenchymal stem cell; OA, osteoarthritis; OP, osteoporosis. 
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clear, and the pathological role of bmMSC in the aging-
related  bone  defects  is  still  under  debate.  An 
understanding  of  the  changes  in  gene  expression  of 
bmMSC with age may provide clues and give insights 
into the basic cause of bone defects during aging. 
 
In  this  study,  using  Illumina  bead  chip  expression 
microarray, we analyzed the gene expression profiles of 
bmMSC  derived  from  14  donors  between  36  and  74 
years  old,  including  many  patients  with  osteoarthritis 
(OA). We identified genes whose change in expression 
was  highly  associated  with  age  or  OA.  Putative 
biological  functions  and  molecular  pathways 
corresponding to those identified genes were retrieved 
by  bioinformatics  analysis,  through  which  a  possible 
pathological  role  of  bmMSC  in  the  development  of 
skeletal diseases in aging was proposed. 
 
Patients and Methods 
 
Isolation of bmMSC from bone marrow 
 
Human  bone  marrows  were  either  collected  from 
osteoarthritis  patients  undergoing  total  knee 
replacement,  or  from  the  femurs  of  healthy  donors 
receiving  bone  surgery  because  of  trauma.  Informed 
consent  was  obtained  from  each  donor.  The  use  of 
human bmMSCs in this study was approved by both the 
Institutional Review Board at National Health Research 
Institutes and Miaoli General Hospital. Bone marrows 
were subjected to ficoll density fractionation to collect 
the  plastic-adherent  mononuclear  cells  as  described 
previously  [7].  These  cells  were  maintained  in  low 
glucose Dulbecco's modified Eagle's medium (GIBCO-
BRL,  California,  USA)  containing  20%  fetal  bovine 
serum  (FBS)  (Hyclone,  Utah,  USA),  glutamine 
(GIBCO-BRL,  California,  USA),  penicillin  and 
streptomycin  (GIBCO-BRL,  California,  USA),  and 
maintained in a humidified atmosphere containing 5% 
CO2 at 37C. After 10-14 days, colonies were dispersed 
and seeded at a density of 1.3 x 10
3 cells/cm
2 (passage 
1),  and  were  passaged  at  70%-80%  confluence 
afterward. Cells of the fourth passage were maintained 
in  medium  containing  10%  FBS  for  4-7  days  and 
subjected  to  flow  cytometric  analysis.  Cultures  that 
were  CD31-  and  CD45-negative,  but  CD90-  and 
CD105-positive were defined as bmMSCs and used for 
RNA extraction [7]. 
 
RNA extraction, microarray experiments, and RT-qPCR 
validation 
 
Total  RNA  was  isolated  from  cells  using  Trizol 
(Invitrogen, Califonia, USA) according to the protocol 
provided  by  the  manufacturer.  Methods  for  sample 
labeling, array experiments, and TaqMan probe-based 
RT-qPCR  experiments,  were  as  described  elsewhere 
[8]. The probes and primers used in RT-qPCR are as 
listed in Supplemental Table SIV. 
 
Statistical analysis 
 
(1)Data  normalization.  To  avoid  possible  unwanted 
technical variation between samples or batches of array, 
raw data from microarray experiments were subject to 
either quantile normalization [9] using preprocessCore 
package  in  the  Bioconductor,  or  global  normalization 
that linearly adjust signal intensity according to signal 
of those spike-in control probes in the Illumina arrays 
(see  supplemental  methods).  Normalized  data  were 
subjected to the following statistical analysis. 
 
(2) Neighborhood analysis. This analysis, developed by 
Golub et al. [10], was used to detect if there were genes, 
in  our  array  data,  showing  strong  correlation  in  their 
expression  with  age  or  OA.  This  analysis  was 
performed as described in supplemental methods. 
 
(3)  Multiple  regression/  criteria  of  probes  selection. 
Multivariate  linear  regression  was  used  to  model  the 
expression  level  of  a  gene  and  its  relation  with  age, 
gender,  or  the  presence  of  OA  of  each  subject.  This 
model is described as follows: 
For probe 1,..., jJ  , let ij Y
be expression data of ith 
individual. For 1,..., iN  , let i A , i G and i D be the 
age,  gender  and  OA  respectively.  In 
particular, 1 i G  if  and  only  if  the ith  individual  is 
male; 1 i D  if and only if the ith individual has OA. 
Assume the gene expression 
 
ij j A i D i G i ij Y A D G            
 
where ,, A D G    and j 
are  the  model  parameters 
and ij 
is  the  error.  Finally,  a  filter  was  applied  to 
remove  probes/genes  having  (i)  average  expression 
level  <  300  arbitrary  units  or  (ii)  p>0.05  in  multiple 
regression analysis, which then generated age-or OA-
associated gene list. Since two normalization methods 
were  applied,  qualified  probes/genes  from  either 
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candidate gene lists. 
 
Measurement of DNA synthesis 
 
DNA  synthesis  was  assessed  by  measuring  the 
incorporation  of  5-bromo-2-deoxyuridine  (BrdU)  into 
DNA using BrdU Cell Proliferation Assay kit  based on 
the protocol provided by manufacturer (Millipore, MA, 
USA).  Briefly,  cells  were  treated  with  BrdU  or 
phosphate  buffer  saline  (PBS, as  background  control) 
for  24  h.  Cells  were  then  fixed  and  DNAs  were 
denatured using Fixing Solution. The BrdU label was 
detected by an anti-BrdU monoclonal antibody, and the 
signals  were  quantitated  with  a  spectrophotometer 
microplate reader set at wavelength of 450/550 nm. 
 
Bioinformatic analysis 
 
We perform gene ontology and pathway analysis using 
Ingenuity  Pathway  Analysis  9.0  for  enrichment  of 
biological functions and pathways in which our selected 
genes of interest were involved. 
 
RESULTS 
 
Age-dependent differences in the growth rate of primary 
cultures of bone marrow-derived plastic-adherent cells 
 
We analyzed the gene expression profiles of bmMSC 
derived  from  14  human  donors.  Donors  1,  5,  and  7 
showed no signs of bone diseases and were designated 
as  healthy  donors,  whereas  the  other  11  donors  were 
osteoarthritis (OA) patients (Table I). 
 
While expanding stem cell populations from each bone 
marrow sample, we counted the plastic-adherent cells 
after  three  and  six  days  post-seeding  at  passage  one, 
calculated the fold increase in cell number for each line 
of bone marrow-derived cells, and correlated the data 
with the age of their donors. As shown in the left panel 
of  Figure  1A,  after  three  days  post-seeding,  the  fold 
increase in cell numbers was negatively correlated with 
the age of donors, although this was not significant (r=-
0.50,  p=0.069).  Nevertheless,  a  rather  significant 
correlation (r=-0.85, p=0.001) was found after six days 
post-seeding  (right  panel,  Figure  1A).  Subsequently, 
these  cells  were  characterized  as  bmMSC  by  flow 
cytometric analyses (Figure 1B). 
 
Quality  assessment  of  genome-wide  microarray  data 
and generation of age- and OA-associated genes 
We noted that under in vitro culture condition, the gene 
expression profile of bmMSC might change with serial 
passaging. Indeed, it has been shown that in vitro aging 
has a similar effect as in vivo aging on human stem cells 
in terms of gene expression profiling [11]. Therefore, in 
this study, all the bmMSC cultures used for the genome-
wide cDNA microarray analysis were harvested at the 
same  passage  (passage  4).  It  should  be  noted  that 
clonogenic  bmMSC  is  a  heterogeneous  mix  of  cells 
containing  the  multipotent  stem  cells  and  their 
progenitors. For convenience, these stem and progenitor 
cells were both named as bmMSC in this study. 
 
The microarray analysis was performed using Illumina 
gene expression chips. Considering that the numbers of 
female donor as well as OA-free donor were low in this 
study, we thought that it would be more proper for us to 
focus on the age-related genes. However, because OA is 
an aging-associated disease, we also examined the gene 
expression  profile  associated  with  OA.  First,  we 
performed  neighborhood  analysis  applying  t-statistics 
(see  Methods)  to  know  if  there  exist  genes  that  are 
associated with age or the presence of OA. The results 
showed  that  the  expression  level  of  many  genes  did 
have strong correlation with either age or the presence 
of OA (supplemental information, Figure S1-A and -B). 
Subsequently, we analyzed the microarray data with a 
multivariate  linear  regression  model  considering  age, 
gender,  and  disease  status  (with  or  without  OA)  as 
covariates. Through such analysis, out of 48804 probes, 
the expression of 574 probes that contain 497 genes was 
found  significantly  correlated  with  age  (p<0.05),  as 
represented  by  20  selected  genes  including  HEXA, 
HEXB,  CTSK,  SULF1,  ADAMTS5,  SPP1,  COL8A2, 
GPNMB, RPL29, TNFAIP6, CDKN2B, etc. (Figure 2, 
see  Discussion).  These  genes  were  named  age-
associated genes (supplemental Table SI). On the other 
hand,  there  were  112  probes  containing  92  genes 
correlated with OA, which were named OA-associated 
genes (supplemental Table SII). There was a moderate 
overlap of only 38 probes (29 genes) between age- and 
OA-associated genes (supplemental Table SIII ). 
 
We performed real-time quantitative PCR (RT-qPCR) 
analyses  on  18  genes  of  interest  selected  from  the 
abovementioned  age-  or  OA-associated  genes  using 
cDNA prepared from selected adult and aged donors, 
and compared the results with array data. We calculated 
the correlation coefficients (r) between array and RT-
qPCR data, and found that 11 of them had r >0.9 and 16 
of them had r >0.8 (Table II). These results indicated 
that, in general, the results of RT-qPCR measurements 
were highly comparable with the array data. 
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Figure  1.  Growth  rate  of  human  bone  marrow-derived  plastic-adherent  cells.    (A) 
Plastic-adherent cells harvested separately from bone marrows of 14 donors were seeded at a 
density of 1.3 x 10
3 cells/cm
2 (passage 1). Cells were counted after 3 days (left panel) and 6 days 
(right  panel)  post-seeding  using  a  hemocytometer,  and  the  fold  increase  in  cell  number  was 
calculated. Donors are color-coded as shown in Table I. (B) Cells harvested 6 days post-seeding 
were subjected to flow cytometric analyses. A representative result is shown. 
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Table I.  Demography of bone marrow donors. 
 
  Gender  Age  Disease  Color code in Figures 1 and 2 
Donor 1  M  36  －    
Donor 2  M  42  OA   
Donor 3   M  43  OA   
Donor 4  M  40  OA   
Donor 5  M  36  －    
Donor 6  F  52  OA   
Donor 7  M  47  －    
Donor 8   M  57  OA   
Donor 9  M  57  OA   
Donor 10  M  69  OA   
Donor 11  M  74  OA   
Donor 12   F  73  OA   
Donor 13  M  71  OA   
Donor 14  F  74  OA   
 
－  means there is no sign of skeletal diseases 
Table I I. Analysis of correlation between microarray data and RT-qPCR measurements. 
 
Gene  r  p    Gene  r  p 
S100A4  0.98  0.0006   TGM2  0.954  0.003094 
GPNMB  0.998  4.78E-06   STC1  0.951  0.003594 
CDH6  0.948  0.004   NEFM  0.371  0.469 
RRAGD  0.888  0.017977   TPI1  0.869  0.024519 
CD55  0.904  0.013265   ADAM19  0.935  0.006163 
CDKN2B  0.971  0.00126   RAC2  0.859  0.028484 
NBL1  0.928  0.0008   AVPI1  0.528  0.282 
SULF1  0.859  0.028523   KRT19  0.948  0.004054 
PPFIBP2  0.888  0.018161      PDE1A  0.966  0.001742 
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Figure 2. Representative plots of donor age versus normalized mRNA expression level 
for selective age-associated genes.  Each solid dot represented a bone marrow donor. The 
regression  lines  (solid  line)  and  correlation  coefficients  (r)  showed  trend  of  change  in  gene 
expression with increasing donor age. Donors are color-coded as shown in Table I. 
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Table I I I. Top GO function terms and canonical pathways enriched by IPA. 
 
         
  Top functions  p value  Top pathways  p value 
Age-associated   Genetic Disorder  2.91E-06-2.01E-02   N-Glycan Degradation  8.91251E-08 
   Metabolic Disease  1.1E-05-1.64E-02   Glycosaminoglycan Degradation  0.00057544 
   Cellular Growth and Proliferation  2.66E-05-1.9E-02   Glycosphingolipid Biosynthesis - Globoseries  0.005754399 
   Cellular Movement  2.94E-05-2.07E-02   Hepatic Fibrosis / Hepatic Stellate Cell Activation  0.00724436 
   Cell Cycle  6.62E-05-2.15E-02   PTEN Signaling  0.011481536 
   Cell Morphology  8.24E-05-1.68E-02   Glycosphingolipid Biosynthesis - Ganglioseries  0.012302688 
   Cellular Development  8.24E-05-1.96E-02   Agrin Interactions at Neuromuscular Junction  0.013803843 
     Skeletal and Muscular System Development 
and Function  1.18E-04-1.96E-02   Aminophosphonate Metabolism  0.013803843 
OA-associated   Nucleic Acid Metabolism  5.26E-04-4E-02   Antigen Presentation Pathway  1.28825E-06 
   Small Molecule Biochemistry  5.26E-04-4E-02 
 Crosstalk between Dendritic Cells and Natural Killer 
Cells  8.70964E-05 
   Cardiovascular System Development and 
Function  8.96E-04-3.51E-02   Allograft Rejection Signaling  0.000933254 
   Cell Morphology  8.96E-04-4.48E-02 
 Cytotoxic T Lymphocyte-mediated Apoptosis of 
Target Cells  0.001348963 
   Cell-To-Cell Signaling and Interaction  8.96E-04-4.97E-02   OX40 Signaling Pathway  0.001862087 
   Cellular Development  8.96E-04-4.97E-02   Cdc42 Signaling  0.003388442 
   Nervous System Development and Function  8.96E-04-4.97E-02 
 Communication between Innate and Adaptive 
Immune Cells  0.006025596 
     Cellular Assembly and Organization  2.23E-03-4.97E-02   Dendritic Cell Maturation  0.006309573 
 
Figure 3. N-glycan degradation pathway enriched by pathway analysis. Enzymes (in EC 
number)  with  their  names  of  coding  genes  and  the  corresponding  sites  of  actions  in  the 
modification of N-glycan are indicated. Genes (n=9) that are differentially expressed with age and 
enriched by IPA analysis are marked in red. 
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Table IV. Genes involved in glycan modification 
 
Gene symbol   Product  Function   
GLT8D2  Glycosyltransferase 8 domain containing 2  glycosyltransferase   
FUCA1  Tissue alpha-L-fucosidase 1  fucosidases   
FUCA2  Tissue alpha-L-fucosidase 2  fucosidases   
MAN1A1  Mannosidase, alpha, class 1A, member 1  mannosidases   
MAN2B2  Mannosidase, alpha, class 2A, member 2  mannosidases   
MANBA  Lysosomal mannosidase, beta A   mannosidases   
NEU1   Lysosomal sialidase 1  Sialidase   
HEXA   Hexosaminidase A (α-polypeptide)  hexosaminidase (glycosylhydrolase) 
HEXB  Hexosaminidase B (β-polypeptide)  hexosaminidase (glycosylhydrolase) 
GM2A   GM2 ganglioside activator  cofactor of hexosaminidase   
ARSB  Arylsulfatase B  sulfatases   
IDS  Iduronate 2-sulfatase  sulfatases   
SULF1  Sulfatase 1  sulfatases   
 
Figure 4. DNA synthesis measured by BrdU incorporation assays. BmMSC from donors 1, 
3, 10, 12, and 13 were seeded into 96-well culture plate (1.2 x 10
2 cells/well). Cells were either left 
untreated or treated with 4, 8, 12, and 16 mM Na2SO4 (Merck, Darmstadt, Germany) for 48 h. 
Then, either BrdU or PBS was added in medium, and cells were incubated for 24 h. Subsequently, 
cells were subjected to detection of the BrdU signals. The fold increase in DNA synthesis was 
calculated by comparing the BrdU signals of Na2SO4 treated cells to that of untreated cells (to 
which a value of 1 was assigned). The gender and age of donors are as indicated in the figure. 
Data represent the mean ± S.D. from three duplicate analyses. **, p<0.05; *, p=0.051 (comparison 
of individual aged sample to the average of adult samples, t-test). 
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associated gene expression changes 
 
To know what cellular functions or molecular pathways 
in  which  the  age-  and  OA-associated  genes  were 
involved,  we  categorized  these  genes  using  the 
Ingenuity  Pathway  Analysis  (IPA).  Table  III 
summarized  the  enriched  top  functions  and  canonical 
pathways.  As  shown,  among  the  top  ranked  Gene 
Ontology  function  terms  enriched  by  age-associated 
genes were cell growth and proliferation (p = 2.7×10
-
5~1.9×10
-2),  cellular  movement  (p  =  2.94×10
-
5~2.07×10
-2),  cell  cycle  (p  =  6.2×10
-5~2.2×10
-2),  and 
cell morphology (p = 8.2×10
-5~1.7×10
-2). These results 
suggested that these cellular functions are most likely to 
change with age in human bmMSC. In spite of these 
results, there was no significant enrichment of specific 
cellular  location  (data  not  shown),  indicating  that  the 
aging-related  cellular  activities  might  take  place  in 
various  cellular  compartments,  rather  than  specific 
locations.  Most  intriguingly,  our  results  showed  that 
pathways for degradation of N-glycans (p = 8.9×10
-8,  
Figure 3), degradation of glycosaminoglycans (GAGs, p 
= 5.7×10
-4), and biosynthesis of glycosphingolipids (p = 
5.7×10
-3) were the top canonical pathways enriched by 
age-associated genes. The ratio of enrichment of genes 
in  a  specific  pathway  was  9/31,  6/71,  and  4/45, 
respectively. 
 
In addition, we found that nucleic acid metabolism (p = 
5.3×10
-4~4.0×10
-2),  small  molecule  biochemistry  (p  = 
5.3×10
-4~4.0×10
-2),  cell  morphology  (p  =  9.0×10
-
4~4.5×10
-2), and cell-to-cell signaling and interaction (p 
=  9.0×10
-4~5.0×10
-2)  were  the  top  ranked  Gene 
Ontology  function  terms,  while  antigen  presentation 
pathway  (p  =  1.3×10
-6),  cross  talk  between  dendritic 
cells and natural killer cells (p = 8.7×10
-5), and allograft 
rejection signaling (p = 9.3×10
-4) were the top canonical 
pathways enriched by the OA-associated genes (Table 
III).  The  ratio  of  enrichment  for  each  corresponding 
pathway was 5/43, 5/98, and 3/97, respectively. These 
results indicated a significant association between OA 
and  bmMSC  with  altered  immunological  functions. 
Moreover, analyses showed that cell-mediated immune 
response,  immunological  disease,  cell  growth  and 
proliferation,  and  cell  cycle  were  among  the  top 
networks  enriched  by  OA-associated  genes  (data  not 
shown). Therefore, like increasing age, OA might also 
associate with alteration in the proliferative capacity of 
bmMSC. On the other hand, we found none of Gene 
Ontology  function  terms  and  pathways  was  enriched 
significantly by those 29 overlapping genes. 
Analysis  of  the  effect  of  sodium  sulfate  on  the  DNA 
synthesis in bmMSC from adult and aged donors 
 
As shown in supplemental Table SI, the expression of 
several sulfatase-encoding genes such as SULF1, ARSB, 
IDS  in  bmMSC  were  up-regulated  with  donor  age. 
Sulfatases  can  desulfate  the  sulfated  proteoglycans  at 
the cell surface, affecting membrane metabolism, signal 
transduction, proliferation, etc, whereas, sodium sulfate 
(Na2SO4)  increases  sulfation  of  proteoglycans  [12]. 
Since elevated levels of various types of sulfatases were 
found in aged donors and aged bmMSCs grew slower in 
culture,  we  tested  whether  attenuation  in  desulfation 
would be able to increase DNA synthesis differentially 
in bmMSCs from aged versus adult donors. Therefore, 
we treated adult (donors 1, 3) and aged (donors 10, 12, 
13)  bmMSCs  with  Na2SO4  of  various  doses  and 
measured  DNA  synthetic  activity  by  BrdU 
incorporation  assays  (Figure  4).  For  bmMSCs  from 
donor 1, 12 mM Na2SO4 induced approximately 20% 
(p<0.01) increase in DNA synthesis, whereas 16 mM 
Na2SO4  did  not  further  increase  DNA  synthesis.  For 
bmMSCs from donor 3, Na2SO4 seemed not to induce 
DNA synthesis. In the aged group, for bmMSCs from 
donor 10, 12 mM Na2SO4 induced approximately 70% 
(p=0.013)  increase  in  DNA  synthesis.  For  bmMSCs 
from donor 12, 16 mM Na2SO4 induced approximately 
60% (p=0.01) increase in DNA synthesis, whereas the 
increase induced by lower Na2SO4 concentration did not 
reach  to  statistical  significance.  For  bmMSCs  from 
donor  13,  8,  12,  and  16  mM  Na2SO4  induced 
approximately  30%  (p=0.041),  40%  (p=0.0014),  and 
50%  (p=0.0013)  increase  in  DNA  synthesis, 
respectively. Moreover, the induction in DNA synthesis 
in  bmMSCs  from  2  out  of  3  aged  donors  was 
significantly  stronger  than  that  in  cells  from  2  adult 
donors at higher Na2SO4 concentration (12 and 16 mM), 
which  coincided  with  our  findings  that  several 
sulfatase-encoding genes in bmMSC were up-regulated 
with donor age. Taken together, these results indicated 
that  aged  bmMSCs  were  more  responsive  to  Na2SO4 
treatment than adult bmMSCs in terms of induction in 
DNA  synthesis,  which  supported  the  notion  that 
elevated  expression  of  sulfatases  might  cause  a 
deleterious  effect  to  the  proliferative  activity  of 
bmMSCs from aged donors. 
 
DISCUSSION 
 
Aged bones are featured by decreased bone mass and 
increased  fragility  compared  with  young  bones. 
Inadequate  bone  formation  following  excessive  bone 
resorption  is  a  major  cause  of  age-related  bone  loss. 
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by inflammatory disease such as OA, as represented by 
the  bone  marrow  donors  in  this  study.  Given  that 
bmMSCs give rise to bone-forming cells, it is likely that 
the aging of bmMSC play an important role in the aging 
of  skeleton,  and  may  be  even  involved  in  the 
development of aging-associated skeletal diseases such 
as osteoporosis (OP) and OA. Unfortunately, molecular 
evidence that can support the above conjecture and link 
aging of bmMSC to OP/OA is still lacking. It is thus of 
great  interest  to  understand  the  age-associated  gene 
expression change to know the role of bmMSC in the 
pathogenesis of aging-related skeletal diseases. In this 
regard, we examined the transcriptome-wide changes of 
genes of bmMSCs derived from 14 donors of various 
age,  and  analyzed  the  array  data  by  exploiting  a 
multivariate  linear  regression  model  considering  all 
known variables, i.e., age, presence of OA, and gender. 
This analytic platform allowed us to correct effects of 
the  OA-  and/or  gender-related  change  of  gene 
expression, to obtain a list of age-dependent genes (in 
the background of OA), and also a list of OA-associated 
genes (in the background of old age). As far as the age-
associated  genes  are  concerned,  our  data  are  in 
agreement  with  the  results  reported  by  Wagner  et  al. 
who  demonstrated  related  effects  of  aging  and 
replicative senescence on the gene expression profiles 
of human bmMSC/progenitors [11]. However, there is 
an overlap of only 8 genes between our and their data. 
These  include  the  age-associated  up-regulation  of 
EPB41L3  and  TCEAL7  involved  in  regulating  cell 
proliferation;  IL13RA2  involved  in  the  signaling  of 
transforming  growth  factor  β1-mediated  fibrosis; 
MFAP5  encoding  a  microfibrillar  associated  protein; 
ROBO1 involved in axon guidance; S100A4 encoding a 
calcium  binding  protein;  STEAP3  involved  in  iron 
metabolism;  and  UBE2E2  involved  in  protein 
degradation. The little overlap might be due in part to 
the differences in the populations studied, cell culture 
conditions, array data processing, or analytical platform 
used.  In  addition  to  the  above  mentioned  genes,  we 
report novel findings about the age- and OA-associated 
changes in the gene expression profiles of bmMSC. 
 
Our data point out that cell growth, proliferation, and 
migration are the cellular functions that most possibly 
change with age in human bmMSC. Among the genes 
involved in these cellular functions are the cell cycle 
regulators-encoding  CCND2,  CCNE1,  and  CDKN2B. 
The former two genes encode D- and E-type cyclins, 
whereas  CDKN2B  encodes  a  cyclin-dependent  kinase 
(CDK)  inhibitor  p15
INK4b  which  arrests  cell  cycle  by 
inhibiting  the  D-type  cyclin-dependent  kinase  CDK4 
activity.  We  observed  that CCND2 and  CDKN2B  are 
up-regulated, but CCNE1 is down-regulated with age. 
Given  the  findings  that  CDK  inhibitors  play  an 
important role in regulating the renewal proliferation of 
mice hematopoietic stem cells [13-15], and that there is 
a strong link between p16
INK4a and cellular aging [13-
16],  our  results  suggest  that  regulation  of  CDKN2B 
expression may play an important role in the renewal 
proliferation  as  well  as  aging  of  human  bmMSC. 
Besides  the  cell  cycle  regulators,  we  found  the  up-
regulation  of  DCN,  PODN,  TP53INP1,  and  DRAM1, 
and  down-regulation  of  ERCC2  and  TGM2  with  age. 
DCN encodes a proteoglycan which down-regulates the 
proliferation  and  migration  of  mammalian  cells  [17]. 
PODN  encodes  an  extracellular  matrix  (ECM) 
component  which  inhibits  cell  growth  and  migration 
[18].  ERCC2  encodes  a  nucleotide  excision  repair 
enzyme  critical  for  removal  of  damaged  DNA 
fragments, while TP53INP1 and DRAM1 participate in 
the DNA damage-triggered growth arrest and apoptosis 
[19, 20]. As for TGM2, it was found to enhance cell 
growth  and  survival  through  anti-apoptosis  signaling 
[21].  Interestingly,  TGFBR3,  RPS6KA2,  PTGER4, 
FBXO32, SULF1, DBC1, TCEAL7, and EPB41L3 are 
up-regulated with age (supplemental Table SI). These 
genes have been reported to negatively control cancer 
cell proliferation [22-29]. Thus, up-regulation of these 
‘tumor  suppressor  genes’  is  likely  to  decrease  the 
proliferation  rate  of  human  bmMSC.  Data  described 
above might underlie the aging-associated decrease in 
the proliferation rate of bmMSCs, an aging phenotype 
of mammalian bmMSCs [3, 30, 31]. Since our data are 
in  agreement  with  the  current  findings  regarding  the 
deleterious effect of aging to the proliferation of stem 
cells, it is conceivable that our results can also reveal 
the other important age-associated functional changes in 
human  bmMSC.  Among  them,  as  revealed  by  our 
analyses, are those involved in glycobiology. 
 
Glycosylation is a cellular process that links glycans to 
macromolecules such as proteins and lipids by different 
types  of  glycosidic  bonds.  N-linked  glycans  (N-
glycans), for example, are the polysaccharides that link 
to  the  peptides  or  proteins  by  N-glycosidic  bond. 
Mature glycoproteins and glycolipids not only form the 
architecture  of  cell  membrane  but  also  participate  in 
cellular signaling. Our results show that several genes 
involved in the modification of glycan are up-regulated 
with age (Table IV and Figure 3). Since modification of 
glycan  is  a  pivotal  process  in  the  synthesis  and 
catabolism  of  glycoproteins  and  glycolipids,  up-
regulation of these genes with age suggests that aging of 
human bmMSC may be accompanied by alterations in 
membrane  homeostasis  and  in  the  glycosylation  of 
membrane  components,  which  may  result  in  the 
alteration  in  cellular  signaling.  For  example, 
hexosaminidase has been implicated in local hydrolysis 
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that glycosphingolipid is the major component of lipid 
rafts  which  play  an  important  role  in  a  variety  of 
cellular processes including signal transduction and cell 
proliferation, elevated expression of HEXA and HEXB 
might enhance the degradation of glycosphingolipids at 
aged  bmMSC  surface,  impact  the  formation  of  lipid 
rafts,  and  affect  signaling.  For  another  example, 
sulfatase  1  is  able  to  desulfate  the  sulfated 
proteoglycans at the cell membrane, inhibits their co-
receptor  functions  in  the  signaling  of  several  growth 
factors. Accordingly, elevated expression of SULF1 in 
aged  bmMSC  is  likely  to  impair  cellular  response  to 
growth factors. In fact, we show that Na2SO4 is able to 
induce DNA synthesis in bmMSCs from adult and aged 
donors, and the induction is stronger in bmMSCs from 
aged donors than in bmMSCs from adult donors (Figure 
4). Based on these findings, we postulate that alterations 
in  the  cellular  functions  regulating  membrane 
homeostasis  and  glycosylation  of  membrane 
components  are  very  likely  to  alter  the  proliferative 
capacity of bmMSC, and play an important role in the 
aging of bmMSC. 
 
In addition, our results have provided clues to address 
the involvement of bmMSC in aging-associated skeletal 
diseases. OA is an inflammatory disease featured by the 
degeneration of cartilage matrix, which is due in part to 
excessive  degradation  of  the  matrix  components 
aggrecan,  collagen  II  and  GAG  [33-35].  It  has  been 
reported that hexosaminidase and sulfatase 1 which are 
involved in the degradation of GAG are the dominant 
enzymes  in  the  synovial  fluid  and  cartilage  of  OA 
patients [36, 37]. Inhibition of hexosaminidase activity 
has  been  proposed  for  preventing  or  even  reversing 
cartilage degradation in OA patients [34]. ADAMTS5, 
an  aggrecanase,  was  also  found  highly  expressed  in 
human  OA  cartilages  [38].  Deletion  of  active 
ADAMTS5  has  been  shown  to  prevent  cartilage 
degradation  in  a  murine  OA  model  [39].  As  to  the 
degradation  of  collagen  II,  cathepsin  K  was  found 
involved  in  the  cleavage  of  collagen  II  in  articular 
cartilages  in  certain  OA  patients,  suggesting  that  it 
might play a role in OA pathology [33]. Our data show 
that genes encoding these enzymes in bmMSCs are all 
up-regulated  with  age.  In  addition,  COL8A2  and 
GPNMB,  two  OA  candidate  genes  [40],  are  also  up-
regulated  with  age  in  bmMSCs. Given  that  bmMSCs 
are  the  primary  source  of  cartilage  chondrocytes,  our 
data  suggest  a  pathological  role  of  aged  bmMSC  in 
aging-associated OA. 
 
Moreover,  the  age-associated  genes  also  cover  genes 
participating  in  regulating  bone  resorption  and 
formation.  Data  show  that  RPL29  is  down-regulated 
with  age  in  human  bmMSC.  RPL29  encodes  a 
ribosomal  protein.  Mice  lacking  this  gene  display  a 
short  stature  phenotype  and  exhibit  increased  bone 
fragility,  which  is  due  to  delayed  entry  of 
osteoprogenitors  into  cell  cycle  and  altered  matrix 
protein synthesis rates [40]. In addition, we show that 
TNFAIP6 is up-regulated with age. This gene has been 
found  down-regulated  during  osteoblastic 
differentiation;  overexpression  of  this  gene  inhibits 
osteoblastic differentiation of human MSCs [41]. Thus, 
down-regulation  of  RPL29  and  up-regulation  of 
TNFAIP6  with  age  may  represent  a  mechanism 
underlying  the  aging-associated  defects  in  bone 
formation  and  osteoblastic  differentiation  of  human 
bmMSC. As mentioned above, cathepsin K may play a 
role in OA pathology, and is up-regulated with age. In 
fact,  there  are  evidences  showing  that  capthesin  K  is 
also implicated in the pathogenesis of OP: (i) cathepsin 
K  has  been  considered  as  a  target  for  the 
pharmacological  treatment  of  OP,  and  (ii) 
overexpression  of  CTSK  has  been  shown  to  cause 
spontaneous development of synovial hyperplasia and 
fibrosis, cartilage degeneration, and bone destruction in 
transgenic  mice  upon  aging  [42].  Therefore,  it  is 
conceivable  that  osteoprogenitors/osteoblasts  with 
elevated  expression  of  CTSK  may  jeopardize  their 
osteogenic  activity.  With  these  in  mind,  it  is  not 
surprising to find that SPP1, an OP susceptibility gene 
[43], is up-regulated with age in bmMSC (supplemental 
Table  SI).  Thus,  our  findings  provide  compelling 
molecular evidences to suggest a role of aged bmMSC 
in  the  pathogenesis  of  OP.  Meanwhile,  it  has  to  be 
mentioned that there is a moderate overlap between age- 
and OA-associated gene lists though, the age-associated 
genes discussed above are only present in the former 
gene list. Taken together, it is tempting to postulate that 
by  associating  with  the  forming  of  pathological  gene 
expression profile described above, increase of age may 
act as an intrinsic promoting factor to the development 
of aging-associated skeletal diseases. 
 
Our analyses of the OA-associated genes have shown 
interesting findings regarding the etiology of OA. Based 
on current theory, OA is the consequence of long term 
mechanical stress on the articular cartilage. In response, 
the  cartilage  chondrocytes  produce  inflammatory 
cytokines  and  matrix  metalloproteinases,  which 
eventually causes destruction of articular cartilage. But 
recently,  a  genome-wide  association  study  (GWAS) 
identified two single nucleotide polymophisms (SNPs) 
which  are  in  a  region  containing  HLA  class  genes 
including HLA-DRB4, associated with susceptibility to 
knee OA [44]. This finding suggests that immunological 
mechanism may be implicated in the etiology of OA. 
Here, we show that antigen presentation and signaling 
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associated genes, and that CD74 and a list of HLA class 
genes  including  HLA-DRB4  are  down-regulated  with 
OA  (Table  III).  Thus,  coinciding  with  that  GWAS 
result, our results also suggest an immunological issue 
associated  with  OA.  Accordingly,  we  propose  that 
bmMSC  with  altered  immunological  property  might 
play an important role in the etiology of OA. On the 
other hand, we found that DAXX which encodes a pro-
apoptotic  factor  in  primary  cells  [45]  is  up-regulated 
with OA. Oppositely, GAS6, SKI, and RAD51 are down-
regulated with OA (supplemental Table SII). Gas6 can 
promote cell proliferation, survival, and migration [46]. 
Ski  can  bind  to  the  histone  deacetylase  SIRT1  and 
inactivate  p53  [47].  Rad51  is  the  major  recombinase 
involved in the repair of DNA double strand breaks. So, 
our  results  suggest  that  the  presence  of  OA  might 
associate  with  deficient  DNA  repair,  and  decreased 
proliferation and survival of bmMSC. 
 
In summary, we have reported novel findings regarding 
to  the  age-  and  OA-associated  changes  in  the  gene 
expression profiles of human bmMSC. We show that 
increase  of  age  and  the  presence  of  OA  may 
independently  associate  with  changes  in  gene 
expression profile that may hinder the proliferation and 
survival of bmMSC. In particular, our results suggest a 
pathological role of aged bmMSC in the development of 
OP and/or aging-associated OA, and also suggest a role 
of bmMSC with altered immunological property in the 
etiology of ‘adult-onset’ OA. 
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